Podcast

Neuro-Oncology: The Podcast

Author: Neuro-Oncology
Feed episode count: 146
Official site: https://soc-neuro-onc.libsyn.com
RSS: https://soc-neuro-onc.libsyn.com/rss
JSON: /v1/public/podcasts/neuro-oncology-the-podcast-1565653
Markdown: /podcast/neuro-oncology-the-podcast-1565653.md

Summary

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Episodes

Jul 24, 2026 · not_requested

Hot Topics: Integrative Neuro-Oncology

Duration seconds: 1859
Source: https://soc-neuro-onc.libsyn.com/hot-topics-integrative-neuro-oncology

HTML Markdown JSON

Jul 10, 2026 · not_requested

SNOBound: Career Advice with Dr. Justin Lathia

Duration seconds: 1053
Source: https://soc-neuro-onc.libsyn.com/snobound-career-advice-with-dr-justin-lathia

HTML Markdown JSON

Jul 6, 2026 · not_requested

Author Interviews: cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas

Duration seconds: 1692
Source: https://soc-neuro-onc.libsyn.com/author-interviews-cimpact-now-update-12-refining-pathology-based-risk-stratification-and-grading-for-idh-mutant-gliomas

HTML Markdown JSON

Jun 26, 2026 · not_requested

A Conversation on Career Journeys with SNO's Young Investigator Committee Chairs

Duration seconds: 1762
Source: https://soc-neuro-onc.libsyn.com/a-conversation-on-career-journeys-with-snos-young-investigator-committee-chairs

HTML Markdown JSON

Jun 19, 2026 · not_requested

Neuro-onc Narratives: Two Insiders, One Diagnosis: A Neurosurgeon and Healthcare Leader on Living with GBM

Duration seconds: 2347
Source: https://soc-neuro-onc.libsyn.com/neuro-onc-narratives-two-insiders-one-diagnosis-a-neurosurgeon-and-healthcare-leader-on-living-with-gbm

HTML Markdown JSON

Jun 15, 2026 · not_requested

Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience

Duration seconds: 972
Source: https://soc-neuro-onc.libsyn.com/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience

HTML Markdown JSON

Jun 1, 2026 · not_requested

Author Interview: Prospective biopsy-controlled validation of an AI model for predicting glioblastoma infiltration: Results from the SupraGlio trial

Duration seconds: 1759
Source: https://soc-neuro-onc.libsyn.com/oauthor-interviews-prospective-biopsy-controlled-validation-of-an-ai-model-for-predicting-glioblastoma-infiltration-results-from-the-supraglio-trial

HTML Markdown JSON

May 30, 2026 · not_requested

Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma

Duration seconds: 199
Source: https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma

HTML Markdown JSON

May 25, 2026 · not_requested

Author Interview Series SNO Podcast May 2026

Duration seconds: 983
Source: https://soc-neuro-onc.libsyn.com/author-interview-series-sno-podcast-may-2026

HTML Markdown JSON

May 18, 2026 · not_requested

Neuro-Oncology Narrative

Duration seconds: 2066
Source: https://soc-neuro-onc.libsyn.com/neuro-oncology-narrative

HTML Markdown JSON

May 15, 2026 · not_requested

Hot Topics: Wellness in Neuro-oncology

Duration seconds: 1477
Source: https://soc-neuro-onc.libsyn.com/hot-topics-wellness-in-neuro-oncology

HTML Markdown JSON

May 11, 2026 · not_requested

Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma

Duration seconds: 236
Source: https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-phase-12-bt008na-trial-focused-ultrasound-temozolomide-for-high-grade-glioma

HTML Markdown JSON

May 8, 2026 · not_requested

SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology

Duration seconds: 1175
Source: https://soc-neuro-onc.libsyn.com/snobound-career-description-and-advice-from-dr-ryan-cecchi-in-neuropathology

HTML Markdown JSON

May 4, 2026 · not_requested

CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma

Duration seconds: 1653
Source: https://soc-neuro-onc.libsyn.com/catnon-conclusion-closure-on-concurrent-chemotherapy-in-idhmt-grade-3-astrocytoma

HTML Markdown JSON

May 1, 2026 · not_requested

Hot Topics: What's next in neuro-oncology

Duration seconds: 1008
Source: https://soc-neuro-onc.libsyn.com/hot-topics-whats-next-in-neuro-oncology

HTML Markdown JSON

Apr 27, 2026 · not_requested

Neuro-Oncology Nugget: Career Development Outreach from SNO

Duration seconds: 191
Source: https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-career-development-outreach-from-sno

HTML Markdown JSON

Apr 24, 2026 · not_requested

Neuro-onc Narratives: An Interview with Caroline Catlin

Duration seconds: 2286
Source: https://soc-neuro-onc.libsyn.com/neuro-onc-narratives-an-interview-with-caroline-catlin

HTML Markdown JSON

Apr 20, 2026 · not_requested

Author Interview: "DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma"

Duration seconds: 2116
Source: https://soc-neuro-onc.libsyn.com/author-interview-dna-copy-number-patterns-reveal-prognostic-markers-and-elucidate-mechanisms-of-evolution-in-idh-mutant-astrocytoma

HTML Markdown JSON

Apr 17, 2026 · not_requested

Hot Topics: AYA in Neuro-Oncology

Duration seconds: 1903
Source: https://soc-neuro-onc.libsyn.com/hot-topics-aya-in-neuro-oncology

HTML Markdown JSON

Apr 13, 2026 · not_requested

Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma

Duration seconds: 149
Source: https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-bivalent-egfril13r2-car-t-cells-for-recurrent-glioblastoma

HTML Markdown JSON

Apr 10, 2026 · not_requested

SNObound: Career Advice from Dr. Brooke Braman in Radiation Oncology

Duration seconds: 1384
Source: https://soc-neuro-onc.libsyn.com/snobound-career-advice-from-dr-brooke-braman-in-radiation-oncology

HTML Markdown JSON

Apr 6, 2026 · not_requested

Author Interview: Global analysis of clinical trials for children and adolescents with CNS tumors

Duration seconds: 1241
Source: https://soc-neuro-onc.libsyn.com/global-analysis-of-clinical-trials-for-children-and-adolescents-with-cns-tumors

HTML Markdown JSON

Mar 23, 2026 · not_requested

Neuro-Oncology Nugget: Intracerebroventricular B7-H3 CAR T Cells for DIPG

Duration seconds: 172
Source: https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-intracerebroventricular-b7-h3-car-t-cells-for-dipg

HTML Markdown JSON

Mar 20, 2026 · not_requested

Neuro-onc Narratives: Advocating for patient well-being in neuro-oncology

Duration seconds: 2570
Source: https://soc-neuro-onc.libsyn.com/neuro-onc-narratives-advocating-for-patient-well-being-in-neuro-oncology-drs-ashlee-loughan-and-sarah-braun

HTML Markdown JSON

Mar 16, 2026 · not_requested

Author Interview: Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma

Duration seconds: 1053
Source: https://soc-neuro-onc.libsyn.com/author-interview-visual-morbidity-long-term-outcome-and-pronostic-factors-in-infants-and-young-children-with-optic-pathway-low-grade-glioma

HTML Markdown JSON

Mar 13, 2026 · not_requested

Hot Topics: Clinician-Patient Relationship in Neuro-Oncology

Duration seconds: 1729
Source: https://soc-neuro-onc.libsyn.com/hot-topics-clinician-patient-relationship-in-neuro-oncology

HTML Markdown JSON

Mar 9, 2026 · not_requested

Neuro-Oncology Nugget: Targeted Radiotherapy Using Rhenium-186 Nanoliposomes for Recurrent Glioma

Duration seconds: 210
Source: https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-targeted-radiotherapy-using-rhenium-186-nanoliposomes-for-recurrent-glioma

HTML Markdown JSON

Mar 6, 2026 · not_requested

SNObound: Career Advice from Dr. Gelareh Zadeh

Duration seconds: 1866
Source: https://soc-neuro-onc.libsyn.com/snobound-dr-gelareh-zadeh

HTML Markdown JSON

Mar 2, 2026 · not_requested

Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma

Duration seconds: 1247
Source: https://soc-neuro-onc.libsyn.com/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma

HTML Markdown JSON